Polygraphy at Home for Neuromuscular Patients Under Non-invasive Mechanical Ventilation
NCT ID: NCT05785637
Last Updated: 2025-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
25 participants
OBSERVATIONAL
2024-03-08
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Regional Distribution of Ventilation to Assess Respiratory Muscle Dysfunction
NCT01569217
Impact of the Type of Interface in Neuromuscular Patients Treated With Nocturnal Noninvasive Ventilation
NCT03458507
Effect of Mechanical Insufflation-exsufflation on Respiratory Parameters in Two Neuromuscular Populations.
NCT02236104
Quality of Life in Ventilator-dependant Neuromuscular Patients
NCT04652401
Natural History of Cardiac and Respiration Function in Patients With Muscular Dystrophies on Home Mechanical Ventilation
NCT02501083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Initiation a non-invasive ventilation at night
Neuromuscular patients with chronic respiratory failure who initiate a non-invasive ventilation at night.
Polygraphy diagnostic at home
Polygraphy diagnostic at home for patients under non-invasive mechanical ventilation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polygraphy diagnostic at home
Polygraphy diagnostic at home for patients under non-invasive mechanical ventilation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with chronic respiratory insufficiency has just been posed non-invasive ventilation (NIV) in the hospital, according to the latest international recommendations ;
* Affiliation to the social security scheme;
* Patient has signed the informed consent form to participate to the study.
Exclusion Criteria
* Patient under guardianship;
* Patient under AME scheme;
* Patients living more than 40 km from reference center;
* Patient depending on mechanical ventilation (more than 6 hours daily);
* Rapidly or reversible evolutive neuro-myopathy (Amyotrophic lateral sclerosis, Guillain Barré syndrome, myasthenia).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association Française contre les Myopathies (AFM), Paris
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric Lofaso, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of physiology and functional explorations - Raymond Poincaré Hospital - APHP
Hélène Prigent, MD, PhD
Role: STUDY_DIRECTOR
Department of physiology and functional explorations - Raymond Poincaré Hospital - APHP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of physiology and functional explorations - Raymond Poincaré Hospital - APHP
Garches, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A01925-38
Identifier Type: REGISTRY
Identifier Source: secondary_id
APHP230176
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.